Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis-Reference-Cited by-同舟云学术

Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis

Published:2021-11-09 Issue: Volume: Page:1201-1218
ISSN:
Container-title:Gastrointestinal and Pancreatico-Biliary Diseases: Advanced Diagnostic and Therapeutic Endoscopy
language:
Short-container-title:

Author:

Leerhøy Bonna,Elmunzer B. Joseph

Publisher

Springer International Publishing

Link

https://link.springer.com/content/pdf/10.1007/978-3-030-56993-8_69

Reference71 articles.

1. Administration USFaD. Infections Associated with Reprocessed Duodenoscopes FDA.gov: U.S. Food and Drug Administration; 2019 updated 29 Aug 2019. Available from: https://www.fda.gov/medical-devices/reprocessing-reusable-medical-devices/infections-associated-reprocessed-duodenoscopes

2. Afghani E, Akshintala VS, Khashab MA et al (2014) 5-Fr vs. 3-Fr pancreatic stents for the prevention of post-ERCP pancreatitis in high-risk patients: a systematic review and network meta-analysis. Endoscopy 46:573–580

3. Akbar A, Abu Dayyeh BK, Baron TH et al (2013) Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a network meta-analysis. Clin Gastroenterol Hepatol 11:778–783

4. Artifon EL, Chu A, Freeman M et al (2010) A comparison of the consensus and clinical definitions of pancreatitis with a proposal to redefine post-endoscopic retrograde cholangiopancreatography pancreatitis. Pancreas 39:530–535

5. Bakman YG, Safdar K, Freeman ML (2009) Significant clinical implications of prophylactic pancreatic stent placement in previously normal pancreatic ducts. Endoscopy 41:1095–1098